Events
- Diabetes Phenotypes: where are we and where do we go from here?
September 6, 2022
Univ. Prof. Dr. DDr h.c. Michael Roden, M.A. E.
CEO of the DDZ (German Diabetes Center) in DüsseldorfIn this webinar, Dr. Roden discussed evidence from recent studies addressing the complexity of diabetes by proposing novel subgroups (subtypes) of diabetes. Several methodological and practical issues need further study: the statistical approach used to define subgroups and derive recommendations for diabetes care; the stability of subgroups over time; the optimal dataset (e.g. phenotypic vs genotypic) for reclassification; the transethnic generalisability of findings; and the applicability in clinical routine care.
- Diabetes in the Lean in India: What Does it Mean?
August 30, 2022
Prof. Nihal Thomas, Mbbs, MD, PhD
Department of Epidemiology, Christian Medical College, VelloreIn this webinar, Dr. Thomas presented his research group's ground-breaking work over the past 15 years on why Indians develop Type 2 Diabaetes at a significantly lower body mass index when compared to their Western counterparts. More specifically, they have investigated: the pathogenesis and aetiology of diabetes in the young in India; epidemiological and GWAS studies in the 50-year-old Vellore birth cohort; basic science research involving individuals with low birth weight, enabled by hyperinsulinemic euglycaemic clamp studies; indirect calorimetry and NMR spectrometry; and next generation sequencing techniques to characterize the patterns of beta cell secretion and insulin resistance defects which are different in Indian and Western populations.
- Diabetes in the US: Good News, Bad News, and Opportunities to Advance Equity
In this webinar, hosted by the Design and Evaluation for Equity Core of the Georgia Center for Diabetes Translation Research, Core Directors Drs. Mohammed K. Ali and Rachel E. Patzer provided an overview of trends in diabetes prevalence, morbidity, and mortality as well as trends in efforts to address diabetes such as utilization of preventive services and treatments and demonstrate how national and state data can be used to explore and highlight key inequities, particularly in ER and inpatient health service use. They showcased ongoing approaches to address health inequities at various levels through implementation science and described the resources and opportunities available at the GCDTR, specifically data and expertise, relevant to both the design and evaluation of diabetes research studies.
To view this EGDRC and Georgia Center for Diabetes Translation Research webinar recorded April 14, click here.
- Precision Medicine for Obesity
Dr. Andres Acosta's research focuses on gastrointestinal physiology to understand the complexity of food intake regulation and obesity. Dr. Acosta is using cutting-edge techniques to develop a unique and novel approach to “personalized obesity management” based on combination of physiology, genetics and metabolic markers.
To view this EGDRC and Georgia Center for Diabetes Translation Research webinar recorded April 14, click here.
- Data, Social Determinants of Health, and Personalized Medicine at the Macro Level
The guiding principle of Dr. Juan Espinoza’s work over the past decade has been that data and technology have the potential to narrow the health gap faced by underserved communities all over the world. This webinar was hosted by the Technologies Advancing Translation and Equity Core of the Georgia Center for Diabetes Translation Research on March 21, 2022.
To view the webinar recording, click here.
- The Pandemic of Diabetes: 100 Years After the Discovery of Insulin Symposium
One hundred years after the discovery of insulin, diabetes rages as a slow and silent killer, already affecting a half a billion people and growing. This symposium was organized in conjunction with the release of a special issue of Endocrinology and Metabolism Clinics of North America, published in collaboration with Elsevier. Topics included genomics, epidemiology, prevention, quality of care, advances in therapeutics, diabetes in special populations, and precision medicine. For more details and agenda click here.
To view the symposium recording, click here.
Positions Available
- Faculty Positions in Artificial Intelligence and Diabetes and Cardiometabolic Diseases
Woodruff Health Sciences Center, Emory University, is seeking to recruit multiple, open-rank tenure-track faculty (assistant, associate, or full professor) with expertise in Artificial Intelligence (AI) and either experience or interest in its application to diabetes and its complications. Emory is making a major commitment to Artificial Intelligence (AI) with the goal of creating a vibrant and coherent research and teaching community that represents the diverse interests of Emory’s schools and units and expand offerings to undergraduate, graduate, and professional school students.
To apply, click here or go to https://faculty-emory.icims.com/jobs and search for “91656”. For additional information contact Mark Hutcheson, mhutch3@emory.edu.
News
- Woodruff Health Sciences Center establishes Emory Global Diabetes Research Center
The Woodruff Health Sciences Center and Emory University are building upon the fundamental and critical research and work conducted by the Global Diabetes Research Center at the Rollins School of Public Health and across the campus to establish the Emory Global Diabetes Research Center (EGDRC) of the Woodruff Health Sciences Center at Emory University. Under the continued leadership of executive director K.M. Venkat Narayan, MD, and co-director Mohammed K. Ali, MD, the center will broaden and grow its work to lessen the burden of diabetes and related non-communicable diseases domestically and globally through research, education and outreach.
The EGDRC will expand its multi-pronged approach to address the problem of diabetes and its associated complications through integrating innovative investigations into the causes and cures for the disease. This includes groundbreaking techniques to explore the root causes of the disease as well as precise ways to personalize medicine for diabetes, interventions to prevent the disease, applications of advanced technologies including artificial intelligence (AI) to improve care delivery, and public health and policy approaches for improving the quality of care and health equity.
Publications
- Recent Publications
Changes in the Incidence of Childhood Obesity. Cunningham SA, Hardy ST, Jones R, Ng C, Kramer MR, Narayan KMV. Pediatrics. (2022) July 05:e2021053708.
Health Consequences of Early-onset Compared with Late-onset Type 2 Diabetes Mellitus. Hou C, Yang H, Qu Yuanyuan, Chen W, Zeng Y, Hu Y, Narayan KMV, Song H, Li D. Precision Clinical Medicine. (2022) 5:pbac015.
Obesity Associated Metabolites in Relation to Type 2 Diabetes Risk: A Prospective Nested Case Control Study of the CARRS Cohort. Ali MK, Kadir MM, Gujrao UP, Fatima S, Iqbal R, Sun YV, Narayan KMV, Ahmad S. Diabetes Obesity & Metabolism. (2022) Jun 8. Online ahead of print.
Trends and Variations in Emergency Department Use Associated With Diabetes in the US by Sociodemographic Factors, 2008-2017. Uppal TS, Chehal PK, Fernandes G, Haw JS, Shah M, Turbow S, Rajpathak S, Narayan KMV, Ali MK. JAMA Network Open. 2022;5(5):e2213867. (2022) May 25
1-h Glucose During Oral Glucose Tolerance Test Predicts Hyperglycemia Relapse-Free Suvival in Obese Black Patients wtih Hyperglycemic Crises. Jagannathan R, Stefanovski D, Smiley DD, Loadejo O, Cotten LF, Umpierrez G, Vellanki P. Frontiers in Endocrinology. (2022) 13: 02 June 2022.
Pathophysiology, Phenotypes and Management of Type 2 Diabetes Mellitus in Indian and Chinese Populations. Ke C, Narayan KMV, Chan JCN, Jha P, Shah BR. Nature Reviews Endocrinology. (2022) 04 May 2022.
Improving Care for Hypertension and Diabetes in India by Addition of Clinical Decision Support System and Task Shifting in the National NCD Program: I-TREC Model of Care. Jindal D, Sharma H, Gupta Y, Ajay VS, Roy A, Sharma R, Ali M, Jarhyan P, Gupta P, Venkateshmurthy NS, Ali MK, Narayan KMV, Prabhakaran D, Weber MB, Mohan S, Pate SA, Tandon N. BMC Health Services Research. (2022) 22:688.
HbA1c, Blood Pressure and Cholesterol control in Adults with Diabetes: A Report Card for Kuwait. Alkandari A, Gujral UP, Bennakhi A, Qabazard S, Al-Wotayan R, Al-Duwairi Q, Al-Kandari H, Narayan KMV, Alarouj M. Journal of Diabetes Investigation. 2022 May 11.
Disparities in Diabetes between US-born and Foreign-born Populations Using Three Diabetes Indicators. Choi D, Narayan KMV, Patel SA. (2022) Biodemography Soc Biol. 2022 Jan-Mar;67(1):16-27. doi: 10.1080/19485565.2021.2016368. Epub 2022 Jan 4. PMC9039242.
Rising Diabetes Diagnosis in Long COVID. Narayan KMV, Staimez LR. (2022) Lancet Diabetes & Endocrinology. Comment. Published online March 21, 2022.
Creating Diabetes Guidelines for the Individual Not Just the Illness. El Sayed NA, Gabbay R, Umpierrez GE. (2022) Lancet Diabetes Endocrinology. 2022 Mar 4;S2213-8587(22)00071-7.
Trends in Depression by Glycemic Status: Serial Cross-Sectional Analyses of the National Health and Nutrition Examination Surveys, 2005-2016. Chandrasekar EK, Ali MK, Wei J, Narayan KV, Owens-Gary MD, Bullard KM. (2022) Primary Care Diabetes. 2022 Mar 7:S1751-9918(22)0061-4.
Association of Obesity, Diabetes, and Alcohol Use With Liver Fibrosis Among US Adulst With Hepatitis C Infection. Midgal AL, Jagannathan R, Qayed I, Cusi K, McCoy RG, Pasquel FJ, Miller LS. (2022) JAMA Network Open. 2022 Mar 1;5(3):32142282.
Declines in Health and Support Between Parents and Adult Children: Insights from Diabetes. Cunningham SA, Beckles GL, Nielsen J. (2022) Population Research and Policy Review. 17 March 2022.
Increased Risk of Incident Diabetes among Individuals with Latent Tuberculosis Infection. Magee MJ, Khakharia A, Gandhi NR, Day CL, Kornfeld H, Rhee MK, Phillips LS. (2022) Diabetes Care. Online ahead of print.
Interventions for Reversing Prediabetes: A Systematic Review and Meta-Analysis. Galaviz KI, Weber MB, Suvada K, Gujral UP, Wei J, Merchant R, Dharanendra S, Haw SJ, Narayan KMV, Ali MK. (2022) American Journal of Preventive Medicine. Online ahead of print.